AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Avecho commences Phase III insomnia trial, page-13

  1. 27,823 Posts.
    lightbulb Created with Sketch. 1351
    The recruitment phase is where I see potential problems arising. The particular cohort required makes this trial very niche............I hope they have done some good dd and are able to recruit the 500+ that they are wanting.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.